50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,647.29
DOW   29,134.99
QQQ   274.48
Layoffs Aren't the Solution to Your Profitability Crisis. Here's the Simple 4-Step Process You Should Be Following Instead.
How You Should Be Choosing Your Stocks (Ad)pixel
Is There Value In These Growth Stocks?
MarketBeat Podcast, 3 Stocks to Watch Newmont Mining, Walmart, AMC
How You Should Be Choosing Your Stocks (Ad)pixel
Build A Better Tech Portfolio With Jabil Inc.
US stocks end mixed a day after Dow entered a bear market
How You Should Be Choosing Your Stocks (Ad)pixel
Autodesk Is A Mature Company Still Acting Like A Growth Stock
Leaks on Russian gas pipelines raise concerns about sabotage
S&P 500   3,647.29
DOW   29,134.99
QQQ   274.48
Layoffs Aren't the Solution to Your Profitability Crisis. Here's the Simple 4-Step Process You Should Be Following Instead.
How You Should Be Choosing Your Stocks (Ad)pixel
Is There Value In These Growth Stocks?
MarketBeat Podcast, 3 Stocks to Watch Newmont Mining, Walmart, AMC
How You Should Be Choosing Your Stocks (Ad)pixel
Build A Better Tech Portfolio With Jabil Inc.
US stocks end mixed a day after Dow entered a bear market
How You Should Be Choosing Your Stocks (Ad)pixel
Autodesk Is A Mature Company Still Acting Like A Growth Stock
Leaks on Russian gas pipelines raise concerns about sabotage
S&P 500   3,647.29
DOW   29,134.99
QQQ   274.48
Layoffs Aren't the Solution to Your Profitability Crisis. Here's the Simple 4-Step Process You Should Be Following Instead.
How You Should Be Choosing Your Stocks (Ad)pixel
Is There Value In These Growth Stocks?
MarketBeat Podcast, 3 Stocks to Watch Newmont Mining, Walmart, AMC
How You Should Be Choosing Your Stocks (Ad)pixel
Build A Better Tech Portfolio With Jabil Inc.
US stocks end mixed a day after Dow entered a bear market
How You Should Be Choosing Your Stocks (Ad)pixel
Autodesk Is A Mature Company Still Acting Like A Growth Stock
Leaks on Russian gas pipelines raise concerns about sabotage
S&P 500   3,647.29
DOW   29,134.99
QQQ   274.48
Layoffs Aren't the Solution to Your Profitability Crisis. Here's the Simple 4-Step Process You Should Be Following Instead.
How You Should Be Choosing Your Stocks (Ad)pixel
Is There Value In These Growth Stocks?
MarketBeat Podcast, 3 Stocks to Watch Newmont Mining, Walmart, AMC
How You Should Be Choosing Your Stocks (Ad)pixel
Build A Better Tech Portfolio With Jabil Inc.
US stocks end mixed a day after Dow entered a bear market
How You Should Be Choosing Your Stocks (Ad)pixel
Autodesk Is A Mature Company Still Acting Like A Growth Stock
Leaks on Russian gas pipelines raise concerns about sabotage
OTCMKTS:QTXB

QuantRx Biomedical - QTXB Stock Forecast, Price & News

$0.0057
0.00 (0.00%)
(As of 09/27/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.0057
$0.0057
50-Day Range
$0.0046
$0.0089
52-Week Range
$0.0045
$0.0170
Volume
10,000 shs
Average Volume
45,100 shs
Market Capitalization
$448,567.20
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About QuantRx Biomedical

QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its products include InSync, a feminine hygienic interlabial pad; Unique miniform, a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad for the daily protection of light urinary, vaginal, or anal leakage; and other treated miniform products. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon.

Receive QTXB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for QuantRx Biomedical and its competitors with MarketBeat's FREE daily newsletter.

QTXB Stock News Headlines

See More Headlines
Receive QTXB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for QuantRx Biomedical and its competitors with MarketBeat's FREE daily newsletter.

QTXB Company Calendar

Today
9/27/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:QTXB
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-260,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
61,462,000
Market Cap
$448,567.20
Optionable
Not Optionable
Beta
-0.33

Key Executives

  • Dr. Shalom Z. Hirschman M.D. (Age 86)
    Chairman, CEO & Principal Accounting Officer













QTXB Stock - Frequently Asked Questions

How have QTXB shares performed in 2022?

QuantRx Biomedical's stock was trading at $0.01 at the beginning of 2022. Since then, QTXB stock has decreased by 43.0% and is now trading at $0.0057.
View the best growth stocks for 2022 here
.

What other stocks do shareholders of QuantRx Biomedical own?
What is QuantRx Biomedical's stock symbol?

QuantRx Biomedical trades on the OTCMKTS under the ticker symbol "QTXB."

How do I buy shares of QuantRx Biomedical?

Shares of QTXB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is QuantRx Biomedical's stock price today?

One share of QTXB stock can currently be purchased for approximately $0.01.

How much money does QuantRx Biomedical make?

QuantRx Biomedical (OTCMKTS:QTXB) has a market capitalization of $448,567.20.

How can I contact QuantRx Biomedical?

QuantRx Biomedical's mailing address is 10190 SW 90TH AVENUE, TUALATIN OR, 97062. The official website for the company is www.quantrx.com. The company can be reached via phone at (212) 980-2235 or via fax at 1-267-880-1596.

This page (OTCMKTS:QTXB) was last updated on 9/28/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.